Gabor J TigyiSummaryPublications
Research Grants
| Collaborators
|
Detail Information
Publications
Aiming drug discovery at lysophosphatidic acid targetsGabor Tigyi
Department of Physiology, University of Tennessee Health Science Center, Memphis, TN, USA
Br J Pharmacol 161:241-70. 2010..However, successful targeting of the pathways associated with this pleiotropic lipid will depend on the future development of as yet undeveloped pharmacons...
Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actionsGyongyi N Kiss
Department of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
Mol Pharmacol 82:1162-73. 2012....
Controlling cancer through the autotaxin-lysophosphatidic acid receptor axisMari Gotoh
Department of Physiology, College of Medicine, University of Tennessee Health Science Center, 894 Union Avenue, Memphis, TN 38163, USA
Biochem Soc Trans 40:31-6. 2012..In the present article, we review some of the key findings that make the ATX-LPA signalling axis an emerging target for cancer therapy...
Research Grants
- Analysis of Radiomitigative Cell SignalingGabor Tigyi; Fiscal Year: 2009..The objective of this grant application is to elucidate the an- tiapoptotic mechanism of action unique to the LPA2 receptor subtype ..
- Ligand Recognition by Phospholipid Growth Factor ReceptorsGabor J Tigyi; Fiscal Year: 2010..Mills at MD Anderson Cancer Center, who will coordinate in vivo testing of anti-metastatic drug candidates, and Dr. Baker (junior faculty), who will assist with photoaffinity labels and mass spectrometry. ..
- Analysis of Radiomitigative Cell SignalingGabor J Tigyi; Fiscal Year: 2010..The objective of this grant application is to elucidate the an- tiapoptotic mechanism of action unique to the LPA2 receptor subtype ..
- Ligand recognition by growth factor receptorsGabor Tigyi; Fiscal Year: 2005..2. Identify residues conferring specificity for sphingolipids in the EDG3/5/6/8 receptor subfamily. 3. Identify residues involved in glycerolipid recognition in the EDG2/4/7 receptor subfamily. ..
- THERAPEUTICALLY PROMISING PHOSPHOLIPID GROWTH FACTORSGabor Tigyi; Fiscal Year: 2006..These studies will have a twofold impact: first, advance our understanding of the physiological function of PLGF; and, second, provide new information concerning the regulation of apoptosis by G protein-coupled receptors. ..
- Analysis of LPA Signaling through the GPCR-PPARgamma AxisGabor Tigyi; Fiscal Year: 2007..abstract_text> ..
- THERAPEUTICALLY PROMISING PHOSPHOLIPID GROWTH FACTORSGabor Tigyi; Fiscal Year: 2002..The biotechnology industry has just begun to explore the utilization of LPA to prevent apoptosis associated with myocardial ischemia, chemotherapy, and AIDS. ..
- Ligand Recognition by Phospholipid Growth Factor ReceptorsGabor Tigyi; Fiscal Year: 2007..Mills at MD Anderson Cancer Center, who will coordinate in vivo testing of anti-metastatic drug candidates, and Dr. Baker (junior faculty), who will assist with photoaffinity labels and mass spectrometry. ..
